← Back
$MPLT All transactions

MapLight Therapeutics, Inc.

▼ SELL

$ Value

$120K

Shares

6,612

Price

$18

Filed

Jan 30

Insider

Name

Malenka Robert C.

Title

CIK

0002021198

Roles

Director

Transaction Details

Transaction Date

2026-01-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

365,273

Footnotes

Represents sales of shares of common stock by the Reporting Person to cover tax obligations in connection with the settlement of restricted stock unit awards. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025. | The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.01 to $19.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.02 to $19.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.13 to $19.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.

Filing Info

Accession No.

0002021198-26-000003

Form Type

4

Issuer CIK

0001770069

Malenka Robert C.'s History

Date Ticker Type Value
2026-04-15 MPLT $231K
2026-02-24 MPLT $13K
2026-02-23 MPLT $198K
2026-02-23 MPLT $9K
2026-02-20 MPLT $40K
2026-02-13 MPLT $221K
2026-02-11 MPLT $4K
2026-02-10 MPLT $120K
2026-02-03 MPLT $18
2026-02-02 MPLT $127K

Other Insiders at MPLT (90d)

Insider Bought Sold Last
Pavlov George $441K 2026-02-20
Garnett Timothy John $253K 2026-02-10
Kroeger Christopher A.
Chief Executive Officer
$521K 2026-04-16
GILLIS JONATHAN
CAAO and PAO
$96K 2026-04-15
Lillie James Woodruff
Chief Scientific Officer
$123K 2026-04-16
Hanson Kristopher
General Counsel
$49K 2026-04-16
Malenka Robert C. $1.5M 2026-04-15
Foff Erin Pennock
Chief Medical Officer
$87K 2026-04-16
Kreitzer Anatol
Chief Discovery Officer
$88K 2026-04-15
Setia Vishwas
Chief Financial Officer
$79K 2026-04-16